Pharming Group N.V. Operating Expense Excluding Cost Of Sales
Pharming Group N.V. (PHAR) reported Operating Expense Excluding Cost Of Sales of $311.32 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:OperatingExpenseExcludingCostOfSales · last filed 2026-04-02
EUR
| Period end | Operating Expense Excluding Cost Of Sales 12 month |
|---|---|
| 2020-12-31 | 99.95M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 87.19M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 75.64M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Operating Expense Excluding Cost Of Sales 12 month |
|---|---|
| 2025-12-31 | $311.32M 20-F · filed 2026-04-02 |
| 2024-12-31 | $272.60M 20-F · filed 2026-04-02 |
| 2023-12-31 | $248.84M 20-F · filed 2026-04-02 |
| 2022-12-31 | $184.35M 20-F · filed 2025-04-03 |
| 2021-12-31 | $166.79M 20-F · filed 2024-04-04 |
| 2020-12-31 | $114.21M 20-F · filed 2023-04-05 |
| 2019-12-31 | $97.70M 20-F · filed 2022-04-06 |